GMED - Globus Medical, Inc.

NYSE - NYSE Delayed Price. Currency in USD
41.95
+0.49 (+1.18%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close41.46
Open41.65
Bid41.85 x 800
Ask41.87 x 800
Day's Range41.20 - 42.23
52 Week Range38.01 - 57.83
Volume369,606
Avg. Volume540,517
Market Cap4.153B
Beta (3Y Monthly)0.94
PE Ratio (TTM)28.34
EPS (TTM)1.48
Earnings DateJul 30, 2019 - Aug 5, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est52.64
Trade prices are not sourced from all markets
  • Markit9 days ago

    See what the IHS Markit Score report has to say about Globus Medical Inc.

    Globus Medical Inc NYSE:GMEDView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for GMED with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting GMED. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding GMED totaled $156 million. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Is Globus Medical, Inc.'s (NYSE:GMED) 12% ROE Better Than Average?
    Simply Wall St.11 days ago

    Is Globus Medical, Inc.'s (NYSE:GMED) 12% ROE Better Than Average?

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

  • Globus Medical (GMED) Down 13.9% Since Last Earnings Report: Can It Rebound?
    Zacks18 days ago

    Globus Medical (GMED) Down 13.9% Since Last Earnings Report: Can It Rebound?

    Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • GlobeNewswire20 days ago

    Globus Medical Launches First Expandable Interspinous Fixation – AERIAL™

    Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced the launch of AERIAL™, a minimally invasive expandable interspinous fixation system with independent locking plates. This is Globus Medical’s first expandable interspinous fixation system, adding to their industry leading expandable technology portfolio. Dr. David Bomback, an orthopedic surgeon and partner at Connecticut Neck and Back Specialists, and Dr. Sumit Das, founder and neurosurgeon with Brain and Spine Neurosurgical Institute, recently performed the first AERIAL™ procedures at Danbury Hospital, Danbury, Connecticut, and Our Lady of Fatima Hospital, North Providence, Rhode Island, respectively.

  • Globus Medical Reveals Positive Study Results for ExcelsiusGPS
    Zacks26 days ago

    Globus Medical Reveals Positive Study Results for ExcelsiusGPS

    Results of the study of ExcelsiusGPS reached a milestone for Globus Medical (GMED) in the field of robotics-assisted, minimally invasive pedicle screw placement procedure

  • GlobeNewswire27 days ago

    New clinical data demonstrates the versatility of Globus Medical’s ExcelsiusGPS®

    Globus Medical (GMED), a leading musculoskeletal solutions company today announced the results of a clinical study that evaluated the versatility of ExcelsiusGPS® Robotic navigation system compared to traditional pedicle screw placement techniques. Published in the Journal of Robotic Surgery, “Robotic-assisted navigated minimally invasive pedicle screw placement in the first 100 cases at a single institution,” demonstrated a 99% screw placement success rate with no malpositions or postoperative returns to the O.R. related to screw placement. The study explored how the ExcelsiusGPS® advanced navigated robotic technology combines the ability to use three imaging workflows (preoperative CT, intraoperative CT, and fluoroscopy) with navigation and guidance to accurately place pedicle screws with real-time feedback.

  • Q1 slump doesn't dim Globus CEO's expectations for robotic surgery system
    American City Business Journalslast month

    Q1 slump doesn't dim Globus CEO's expectations for robotic surgery system

    Despite a first quarter sales slump, Globus Medical continues to be "bullish" about its robotic-assisted navigation and surgical system.  The Audubon medical products company launched the system, called ExcelsiusGPS, in late 2017. The ExcelsiusGPS system, which costs slightly more than $1 million, combines a rigid robotic arm and full navigation capabilities to provide surgeons with precise trajectory alignment in minimally invasive spine surgery.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of GMED earnings conference call or presentation 2-May-19 8:30pm GMT

    Q1 2019 Globus Medical Inc Earnings Call

  • Globus Medical (GMED) Q1 Earnings Miss, Revenues Grow Y/Y (Revised)
    Zackslast month

    Globus Medical (GMED) Q1 Earnings Miss, Revenues Grow Y/Y (Revised)

    Globus Medical (GMED) management states that the first quarter of a year poses a seasonal challenge to the company's capital equipment, which grossly affects its sales in Q1.

  • Globus Medical (GMED) Q1 Earnings Miss Mark, Margins Weak
    Zacks2 months ago

    Globus Medical (GMED) Q1 Earnings Miss Mark, Margins Weak

    Globus Medical (GMED) management states that the first quarter of a year poses a seasonal challenge to the company's capital equipment, which grossly affects its sales in Q1.

  • Globus Medical Inc (GMED) Q1 2019 Earnings Call Transcript
    Motley Fool2 months ago

    Globus Medical Inc (GMED) Q1 2019 Earnings Call Transcript

    GMED earnings call for the period ending March 31, 2019.

  • Globus Medical (GMED) Q1 Earnings and Revenues Miss Estimates
    Zacks2 months ago

    Globus Medical (GMED) Q1 Earnings and Revenues Miss Estimates

    Globus Medical (GMED) delivered earnings and revenue surprises of -12.20% and -1.90%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press2 months ago

    Globus Medical: 1Q Earnings Snapshot

    On a per-share basis, the Audubon, Pennsylvania-based company said it had profit of 33 cents. Earnings, adjusted for one-time gains and costs, came to 36 cents per share. The results fell short of Wall ...

  • GlobeNewswire2 months ago

    Globus Medical Reports First Quarter 2019 Results

    AUDUBON, Pa., May 02, 2019 -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended.

  • What Should Investors Know About Globus Medical, Inc.'s (NYSE:GMED) Earnings Trajectory?
    Simply Wall St.2 months ago

    What Should Investors Know About Globus Medical, Inc.'s (NYSE:GMED) Earnings Trajectory?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Globus Medical, Inc.'s (NYSE:GMED) most recent earnings update in December 2018 confirmed...

  • Here’s What Hedge Funds Think About Globus Medical Inc (GMED)
    Insider Monkey2 months ago

    Here’s What Hedge Funds Think About Globus Medical Inc (GMED)

    Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge funds’ stock picking abilities to illustrate. The Standard and Poor’s 500 Index returned approximately 13.1% in the 2.5 months of 2019 (including […]

  • Globus Medical (GMED) Reports Next Week: What Awaits?
    Zacks2 months ago

    Globus Medical (GMED) Reports Next Week: What Awaits?

    Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire2 months ago

    Globus Medical Schedules First Quarter 2019 Earnings Release and Conference Call

    AUDUBON, Pa., April 17, 2019 -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended.

  • Will Globus Medical, Inc.'s (NYSE:GMED) Earnings Grow In The Year Ahead?
    Simply Wall St.2 months ago

    Will Globus Medical, Inc.'s (NYSE:GMED) Earnings Grow In The Year Ahead?

    Since Globus Medical, Inc. (NYSE:GMED) released its earnings in December 2018, it seems that analyst expectations are fairly bearish, as a 8.6% rise in profits is expected in th...

  • GlobeNewswire2 months ago

    Globus Medical Launches FORTIFY Variable Angle Expandable Corpectomy Spacer System

    Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced the launch of FORTIFY VA™, a variable angle corpectomy solution, to add to its large and growing Expandable Technology portfolio.  Globus Medical is the industry leader in expandable technology with over 20 expandable implant options backed by 15 years of engineering, testing, and clinical experience.  The company’s Expandable Technology portfolio consists of the most innovative devices on the market, designed to improve clinical results using minimally invasive surgery (MIS) approaches. Building on Globus Medical’s experience and innovation, FORTIFY VA™ is an expandable corpectomy spacer designed to optimize anatomical fit using an anterior cervical approach or one of several approaches to the thoracolumbar spine.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of GMED earnings conference call or presentation 21-Feb-19 9:30pm GMT

    Q4 2018 Globus Medical Inc Earnings Call